Explore Business Standard
Explore Business Standard
The revenue stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Operating Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
PBDT stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Profit Before Tax stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This corresponds to a year-on-year *(YoY) decline of per cent.
Net Profit stands at ₹ crore, reflecting a quarter-on-quarter *(QoQ) decrease of per cent from ₹ crore. This represents a per cent year-on-year *(YoY) decline for the same year.
| Category | Q3 FY25-26 | Q3 FY24-25 | Change % | FY24-25 | FY23-24 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 3,303.00 | 2,809.00 | 17.59 | 11,516.00 | 10,728.00 | 7.35 |
| Expenses | 2,225.00 | 1,895.00 | 17.41 | 7,819.00 | 7,360.00 | 6.24 |
| Other Income | -13.00 | 33.00 | -139.39 | 23.00 | 146.00 | -84.25 |
| Operating Profit | 1,078.00 | 914.00 | 17.94 | 3,720.00 | 3,514.00 | 5.86 |
| Depreciation | 206.00 | 199.00 | 3.52 | 795.00 | 808.00 | -1.61 |
| Interest | 45.00 | 57.00 | -21.05 | 252.00 | 354.00 | -28.81 |
| Profit Before Tax | 814.00 | 691.00 | 17.80 | 2,673.00 | 2,352.00 | 13.65 |
| Tax | 179.00 | 188.00 | -4.79 | 619.00 | 462.00 | 33.98 |
| Net Profit | 635.00 | 503.00 | 26.24 | 1,911.00 | 1,656.00 | 15.40 |
| Category | Q3 FY25-26 | Q3 FY24-25 | Change % | FY24-25 | FY23-24 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 2,599.00 | 2,377.00 | 9.34 | 9,682.00 | 8,533.00 | 13.47 |
| Expenses | 1,609.00 | 1,490.00 | 7.99 | 6,131.00 | 5,643.00 | 8.65 |
| Other Income | -8.00 | 3.00 | -366.67 | 32.00 | 91.00 | -64.84 |
| Operating Profit | 1,997.00 | 1,841.00 | 8.47 | 3,583.00 | 2,981.00 | 20.19 |
| Depreciation | 191.00 | 191.00 | 0 | 760.00 | 761.00 | -0.13 |
| Interest | 34.00 | 48.00 | -29.17 | 213.00 | 303.00 | -29.70 |
| Profit Before Tax | 757.00 | 651.00 | 16.28 | 2,610.00 | 1,917.00 | 36.15 |
| Tax | 180.00 | 166.00 | 8.43 | 541.00 | 322.00 | 68.01 |
| Net Profit | 577.00 | 485.00 | 18.97 | 1,888.00 | 1,357.00 | 39.13 |
| Category | Q3 FY25-26 | Q2 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 3,303.00 | 3,302.00 | 0.03 |
| Expenses | 2,225.00 | 2,232.00 | -0.31 |
| Other Income | -13.00 | -27.00 | -51.85 |
| Operating Profit | 1,078.00 | 1,070.00 | 0.75 |
| Depreciation | 206.00 | 204.00 | 0.98 |
| Interest | 45.00 | 48.00 | -6.25 |
| Profit Before Tax | 814.00 | 791.00 | 2.91 |
| Tax | 179.00 | 200.00 | -10.50 |
| Net Profit | 635.00 | 591.00 | 7.45 |
| Category | Q3 FY25-26 | Q2 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 2,599.00 | 2,762.00 | -5.90 |
| Expenses | 1,609.00 | 1,703.00 | -5.52 |
| Other Income | -8.00 | -27.00 | -70.37 |
| Operating Profit | 1,997.00 | 2,113.00 | -5.49 |
| Depreciation | 191.00 | 189.00 | 1.06 |
| Interest | 34.00 | 37.00 | -8.11 |
| Profit Before Tax | 757.00 | 806.00 | -6.08 |
| Tax | 180.00 | 209.00 | -13.88 |
| Net Profit | 577.00 | 597.00 | -3.35 |
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Data Not Found | ||||||
Torrent Pharmaceuticals Ltd on Friday said the central GST authority has imposed a penalty of over Rs 41 crore on the company for alleged erroneous refund on export of goods. The Joint Commissioner, Common Adjudicating Authority, Central GST, Ahmedabad South Commissionerate passed an order imposing a penalty of Rs 41,33,84,165, Torrent Pharmaceuticals Ltd said in a regulatory filing. The order dated November 26, 2025 alleges erroneous refund by department on export of goods, it added. The company further said based on its assessment, an appeal will be filed and is hopeful of favourable outcome and does not reasonably expect the order to have any material financial impact on it.
Fair trade regulator CCI on Tuesday cleared Torrent Pharmaceuticals Ltd's proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies. The development came after Torrent Pharmaceuticals in June this year announced the acquisition of a majority stake in JB Chemicals and Pharmaceuticals in a Rs 19,500-crore deal. "The proposed combination relates to the acquisition of shareholding by Torrent Pharmaceuticals Ltd (acquirer) in JB Chemicals & Pharmaceuticals Ltd (target) and the subsequent amalgamation of the target with the acquirer," the regulator said in a release. After the completion of the deal, Torrent Pharmaceuticals will become India's second most valued pharma company. "The Commission approved the proposed combination subject to compliance with voluntary modifications offered by the parties (Torrent Pharmaceuticals Ltd and JB Chemicals & Pharmaceuticals Ltd)," it added. Torrent Pharmaceuticals is the ...
